These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12692230)

  • 1. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
    Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
    J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
    Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
    Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
    Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
    Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
    Mori N; Yamada Y; Ikeda S; Yamasaki Y; Tsukasaki K; Tanaka Y; Tomonaga M; Yamamoto N; Fujii M
    Blood; 2002 Sep; 100(5):1828-34. PubMed ID: 12176906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
    Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
    Dewan MZ; Uchihara JN; Terashima K; Honda M; Sata T; Ito M; Fujii N; Uozumi K; Tsukasaki K; Tomonaga M; Kubuki Y; Okayama A; Toi M; Mori N; Yamamoto N
    Blood; 2006 Jan; 107(2):716-24. PubMed ID: 16174765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N
    J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.
    Okudaira T; Tomita M; Uchihara JN; Matsuda T; Ishikawa C; Kawakami H; Masuda M; Tanaka Y; Ohshiro K; Takasu N; Mori N
    Mol Cancer Ther; 2006 Mar; 5(3):704-12. PubMed ID: 16546985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.
    Ohsugi T; Horie R; Kumasaka T; Ishida A; Ishida T; Yamaguchi K; Watanabe T; Umezawa K; Urano T
    Carcinogenesis; 2005 Aug; 26(8):1382-8. PubMed ID: 15831528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Haneji K; Matsuda T; Tomita M; Kawakami H; Ohshiro K; Uchihara JN; Masuda M; Takasu N; Tanaka Y; Ohta T; Mori N
    Nutr Cancer; 2005; 52(2):189-201. PubMed ID: 16201850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
    Kawano N; Ishikawa F; Shimoda K; Yasukawa M; Nagafuji K; Miyamoto T; Baba E; Tanaka T; Yamasaki S; Gondo H; Otsuka T; Ohshima K; Shultz LD; Akashi K; Harada M
    Leukemia; 2005 Aug; 19(8):1384-90. PubMed ID: 15959532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
    Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
    Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.
    Ohsugi T; Kumasaka T; Okada S; Ishida T; Yamaguchi K; Horie R; Watanabe T; Umezawa K
    Cancer Lett; 2007 Nov; 257(2):206-15. PubMed ID: 17764832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines.
    Okudaira T; Hirashima M; Ishikawa C; Makishi S; Tomita M; Matsuda T; Kawakami H; Taira N; Ohshiro K; Masuda M; Takasu N; Mori N
    Int J Cancer; 2007 May; 120(10):2251-61. PubMed ID: 17278100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2RĪ³null mouse model.
    Masaki A; Ishida T; Suzuki S; Ito A; Mori F; Sato F; Narita T; Yamada T; Ri M; Kusumoto S; Komatsu H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
    J Immunol; 2013 Jul; 191(1):135-44. PubMed ID: 23733874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice.
    Dewan MZ; Watanabe M; Ahmed S; Terashima K; Horiuchi S; Sata T; Honda M; Ito M; Watanabe T; Horie R; Yamamoto N
    Cancer Sci; 2005 Aug; 96(8):466-73. PubMed ID: 16108827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.
    Keller SA; Hernandez-Hopkins D; Vider J; Ponomarev V; Hyjek E; Schattner EJ; Cesarman E
    Blood; 2006 Apr; 107(8):3295-302. PubMed ID: 16380446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice.
    Stewart SA; Feuer G; Jewett A; Lee FV; Bonavida B; Chen IS
    Virology; 1996 Dec; 226(2):167-75. PubMed ID: 8955035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.
    Satou Y; Nosaka K; Koya Y; Yasunaga JI; Toyokuni S; Matsuoka M
    Leukemia; 2004 Aug; 18(8):1357-63. PubMed ID: 15190257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.